Trupanion, Inc. (NASDAQ:TRUP) Given Average Recommendation of “Hold” by Analysts

Shares of Trupanion, Inc. (NASDAQ:TRUPGet Free Report) have been given an average rating of “Hold” by the six brokerages that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $42.25.

TRUP has been the subject of a number of research reports. Stifel Nicolaus lowered their price objective on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research report on Tuesday, March 31st. Weiss Ratings cut Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 4th. Cantor Fitzgerald decreased their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Piper Sandler decreased their target price on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Finally, Bank of America decreased their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th.

Check Out Our Latest Stock Report on TRUP

Insider Transactions at Trupanion

In other news, CRO Emily Dreyer sold 7,792 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $28.15, for a total transaction of $219,344.80. Following the completion of the transaction, the executive directly owned 35,627 shares in the company, valued at approximately $1,002,900.05. The trade was a 17.95% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 2,837 shares of the business’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $26.46, for a total value of $75,067.02. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 16,773 shares of company stock worth $457,309. 5.42% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Trupanion

Several institutional investors have recently modified their holdings of TRUP. Royal Bank of Canada grew its position in shares of Trupanion by 60.6% during the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock worth $1,109,000 after buying an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Trupanion by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock valued at $731,000 after purchasing an additional 858 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Trupanion by 73.5% during the 1st quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after purchasing an additional 113,490 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Trupanion by 35.1% during the 2nd quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock valued at $10,392,000 after purchasing an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC bought a new position in shares of Trupanion during the 2nd quarter valued at about $249,000.

Trupanion Price Performance

Shares of TRUP stock opened at $21.86 on Wednesday. The stock has a 50-day moving average price of $25.16 and a 200 day moving average price of $30.66. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. The firm has a market cap of $953.53 million, a price-to-earnings ratio of 37.05 and a beta of 1.49. Trupanion has a 12 month low of $21.16 and a 12 month high of $57.88.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. The firm had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The company’s revenue was up 12.3% on a year-over-year basis. During the same period last year, the company earned ($0.03) earnings per share. Research analysts expect that Trupanion will post 0.53 EPS for the current year.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Read More

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.